All Publications
Kolak, A. ; Tschuck, J. ; Weiss, S.A. ; Kaemena, D.F. ; Klimm, K. ; Galhoz, A. ; Ringelstetter, L. ; Fennell, M. ; Merl-Pham, J. ; Artati, A. ; Strasser, S. ; Garippa, R. ; Witting, M. ; Zischka, H. ; Schick, J. ; Hauck, S.M. ; Menden, M.P. ; Vincendeau, M. ; Stockwell, B.R. ; Hadian, K.
miR-940 suppresses ferroptosis by controlling expression of key regulatory genes.Sinitsyn, S. ; Klianitskaya, M. ; Vincendeau, M. ; Pačes, J. ; Frishman, D.
Current status of human endogenous retrovirus annotation.Lorenz, S. ; Wahida, A. ; Bostock, M.J. ; Seibt, T. ; Santos Dias Mourão, A. ; Levkina, A. ; Trümbach, D. ; Soudy, M. ; Emler, D. ; Rothammer, N. ; Woo, M.S. ; Sonner, J.K. ; Novikova, M. ; Henkelmann, B. ; Aldrovandi, M. ; Kaemena, D.F. ; Mishima, E. ; Vermonden, P. ; Zong, Z. ; Cheng, D. ; Nakamura, T. ; Ito, J. ; Doll, S. ; Proneth, B. ; Bürkle, E. ; Rizzollo, F. ; Escamilla Ayala, A. ; Napolitano, V. ; Kolonko, M. ; Gaussmann, S. ; Merl-Pham, J. ; Hauck, S.M. ; Pertek, A. ; Orschmann, T. ; Van San, E. ; Vanden Berghe, T. ; Hass, D, ; Maida, A. ; Frenz, J.M. ; Pedrera, L. ; Dolga, A.M. ; Kraiger, M. ; Hrabě de Angelis, M. ; Fuchs, H. ; Ebert, G. ; Lenberg, J. ; Friedman, J. ; Scale, C. ; Agostinis, P. ; Zimprich, A. ; Vogt Weisenhorn, D.M. ; Garrett, L. ; Hölter, S.M. ; Wurst, W. ; Glaab, E. ; Lewerenz, J. ; Popper, B. ; Sieben, C. ; Steinacker, P. ; Zischka, H. ; García-Sáez, A.J. ; Tietze, A. ; Ramesh, S.K. ; Ayton, S. ; Vincendeau, M. ; Friese, M.A. ; Wigby, K. ; Sattler, M. ; Mann, M. ; Ingold, I. ; Jayavelu, A.K. ; Popowicz, G.M. ; Conrad, M.
A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosis.Özer, S. ; Strobelt, R. ; Kosinska, A. ; Frishman, G. ; Wettengel, J.M. ; Pleninger, L. ; Körber, N. ; Liang, W. ; Ates Öz, E. ; Zuniga, M. ; Bauer, T. ; Ebert, G. ; Protzer, U. ; Vincendeau, M.
HERV-K10 as a mediator of immune modulation in hepatitis infections.Liang, W. ; Stubbe, M. ; Pleninger, L. ; Hofferek, A. ; Stubbe, H.C. ; Mai, J. ; Özer, S. ; Frishman, D. ; Schreiner, S. ; Vincendeau, M.
HERV reactivation by adenovirus infection is associated with viral immune regulation.Tschuck, J. ; Padmanabhan Nair, V. ; Galhoz, A. ; Zaratiegui, C. ; Tai, H.-M. ; Ciceri, G. ; Rothenaigner, I. ; Tchieu, J. ; Stockwell, B.R. ; Studer, L. ; Cabianca, D.S. ; Menden, M.P. ; Vincendeau, M. ; Hadian, K.
Suppression of ferroptosis by vitamin A or radical-trapping antioxidants is essential for neuronal development.Sai, M. ; Hank, E.C. ; Tai, H.-M. ; Kasch, T. ; Lewandowski, M. ; Vincendeau, M. ; Marschner, J.A. ; Merk, D.J.
Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing.Tschuck, J. ; Theilacker, L. ; Rothenaigner, I. ; Weiss, S.A. ; Akdogan, B. ; Lam, T.V. ; Müller, C. ; Graf, R. ; Brandner, S. ; Pütz, C. ; Rieder, T. ; Schmitt-Kopplin, P. ; Vincendeau, M. ; Zischka, H. ; Schorpp, K.K. ; Hadian, K.
Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis.Liu, H. ; Bergant, V. ; Frishman, G. ; Ruepp, A. ; Pichlmair, A. ; Vincendeau, M. ; Frishman, D.
Influenza A virus infection reactivates human endogenous retroviruses associated with modulation of antiviral immunity.Padmanabhan Nair, V. ; Mayer, J. ; Vincendeau, M.
A protocol for CRISPR-mediated activation and repression of human endogenous retroviruses in human pluripotent stem cells.Jakobsson, J. ; Vincendeau, M.
SnapShot: Human endogenous retroviruses.Weber, M. ; Padmanabhan Nair, V. ; Bauer, T. ; Sprinzl, M.F. ; Protzer, U. ; Vincendeau, M.
Increased HERV-K(HML-2) transcript levels correlate with clinical parameters of liver damage in hepatitis C patients.Padmanabhan Nair, V. ; Liu, H. ; Ciceri, G. ; Jungverdorben, J. ; Frishman, G. ; Tchieu, J. ; Cederquist, G.Y. ; Rothenaigner, I. ; Schorpp, K.K. ; Klepper, L. ; Walsh, R.M. ; Kim, T.W. ; Cornacchia, D. ; Ruepp, A. ; Mayer, J. ; Hadian, K. ; Frishman, D. ; Studer, L. ; Vincendeau, M.
Activation of HERV-K(HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3.Pabis, M. ; Corsini, L. ; Vincendeau, M. ; Tripsianes, K. ; Gibson, T.J. ; Brack-Werner, R. ; Sattler, M.
Modulation of HIV-1 gene expression by binding of a ULM motif in the Rev protein to UHM-containing splicing factors.Brenke, J.K. ; Popowicz, G.M. ; Schorpp, K.K. ; Rothenaigner, I. ; Roesner, M. ; Meininger, I. ; Kalinski, C. ; Ringelstetter, L. ; R'kyek, O. ; Jürjens, G. ; Vincendeau, M. ; Plettenburg, O. ; Sattler, M. ; Krappmann, D. ; Hadian, K.
Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity.Krappmann, D. ; Vincendeau, M.
Mechanisms of NF-κB deregulation in lymphoid malignancies.Bognar, M. ; Vincendeau, M. ; Erdmann, T. ; Seeholzer, T. ; Grau, M. ; Linnemann, J. ; Ruland, J. ; Scheel, C. ; Lenz, P. ; Ott, G. ; Lenz, G. ; Hauck, S.M. ; Krappmann, D.
Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.Vincendeau, M. ; Hadian, K. ; Messias, A.C. ; Brenke, J.K. ; Halander, J. ; Griesbach, R.A. ; Greczmiel, U. ; Bertossi, A. ; Stehle, R. ; Nagel, D. ; Demski, K. ; Velvarska, H. ; Niessing, D. ; Geerlof, A. ; Sattler, M. ; Krappmann, D.
Inhibition of canonical NF-κB signaling by a small molecule targeting NEMO-ubiquitin interaction.Nagel, D. ; Bognar, M. ; Eitelhuber, A.C. ; Kutzner, K. ; Vincendeau, M. ; Krappmann, D.
Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma.Vincendeau, M. ; Göttesdorfer, I. ; Schreml, J. ; Wetie, A. ; Mayer, J. ; Greenwood, A.D. ; Helfer, M. ; Kramer, S. ; Seifarth, W. ; Hadian, K. ; Brack-Werner, R. ; Leib-Mösch, C.
Modulation of Human Endogenous Retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.Vincendeau, M. ; Krappmann, D. ; Hadian, K.
In vitro detection of NEMO-ubiquitin binding using DELFIA and microscale thermophoresis assays.Schimmack, G. ; Eitelhuber, A.C. ; Vincendeau, M. ; Demski, K. ; Shinohara, H. ; Kurosaki, T. ; Krappmann, D.
AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-kappa B signaling upon T cell activation.Nagel, D. ; Vincendeau, M. ; Eitelhuber, A.C. ; Krappmann, D.
Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.Maliniemi, P. ; Vincendeau, M. ; Mayer, J. ; Frank, O. ; Hahtola, S. ; Karenko, L. ; Carlsson, E. ; Mallet, F. ; Seifarth, W. ; Leib-Mösch, C. ; Ranki, A.
Expression of human endogenous retrovirus-W including syncytin-1 in cutaneous T-cell lymphoma.Vincendeau, M. ; Nagel, D. ; Eitelhuber, A.C. ; Krappmann, D.
MALT1 paracaspase: A unique protease involved in B-cell lymphomagenesis.Schlauderer, F. ; Lammens, K. ; Nagel, D. ; Vincendeau, M. ; Eitelhuber, A.C. ; Verhelst, S.H. ; Kling, D. ; Chrusciel, A. ; Ruland, J. ; Krappmann, D. ; Hopfner, K.-P.
Structural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspase.Manic, G. ; Maurin-Marlin, A. ; Laurent, F. ; Vitale, I. ; Thierry, S. ; Delelis, O. ; Dessen, P. ; Vincendeau, M. ; Leib-Mösch, C. ; Hazan, U. ; Mouscadet, J.F. ; Bury-Moné, S.
Impact of the Ku complex on HIV-1 expression and latency.Vincendeau, M. ; Nagel, D. ; Brenke, J.K. ; Brack-Werner, R. ; Hadian, K.
Heterogenous nuclear ribonucleoprotein Q increases protein expression from HIV-1 Rev-dependent transcripts.Nagel, D. ; Spranger, S. ; Vincendeau, M. ; Grau, M. ; Raffegerst, S.H. ; Kloo, B. ; Hlahla, D. ; Neuenschwander, M. ; von Kries, J.P. ; Hadian, K. ; Dörken, B. ; Lenz, P. ; Lenz, G. ; Schendel, D.J. ; Krappmann, D.
Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL.Meggendorfer, M. ; Rothenaigner, I. ; Tigges, B. ; Vincendeau, M. ; Brack-Werner, R.
Neurotoxicity of HIV-1 Proteins.Vincendeau, M.
Influence of the exogenous virus HIV-1 on the expression of human endogenous retroviral elements (HERVs).Haupt, S. ; Tisdale, M. ; Vincendeau, M. ; Clements, M.A. ; Gauthier, D.T. ; Lance, R. ; Semmes, O.J. ; Turqueti-Neves, A. ; Nößner, E. ; Leib-Mösch, C. ; Greenwood, A.D.
Human endogenous retrovirus transcription profiles of the kidney and kidney-derived cell lines.Greenwood, A.D. ; Vincendeau, M. ; Schmädicke, A.C. ; Montag, J. ; Seifarth, W. ; Motzkus, D.
Bovine spongiform encephalopathy infection alters endogenous retrovirus expression in distinct brain regions of cynomolgus macaques (Macaca fascicularis).Kloo, B. ; Nagel, D. ; Pfeifer, M. ; Grau, M. ; Düwel, M. ; Vincendeau, M. ; Dörken, B. ; Lenz, P. ; Lenz, G. ; Krappmann, D.
Critical role of PI3K signaling for NF-κB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells.Vincendeau, M. ; Kramer, S. ; Hadian, K. ; Rothenaigner, I. ; Bell, J. ; Hauck, S.M. ; Bickel, C. ; Nagel, D. ; Kremmer, E. ; Werner, T. ; Leib-Mösch, C. ; Brack-Werner, R.
Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp).Meyer, N.H. ; Tripsianes, K. ; Vincendeau, M. ; Madl, T. ; Kateb, F. ; Brack-Werner, R. ; Sattler, M.
Structural basis for homodimerization of the Src-associated during mitosis, 68-kDa protein (Sam68) Qua1 domain.Hadian, K. ; Vincendeau, M. ; Mäusbacher, N. ; Nagel, D. ; Hauck, S.M. ; Ueffing, M. ; Loyter, A. ; Werner, T. ; Wolff, H. ; Brack-Werner, R.
Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein.Vincendeau, M. ; Kramer, S. ; Hadian, K. ; Rothenaigner, I. ; Bell, J. ; Hauck, S.M. ; Bickel, C. ; Kremmer, E. ; Leib-Mösch, C. ; Brack-Werner, R.
A novel family of host cell factors that control hiv production by targeting rev.Vincendeau, M. ; Schreml, J. ; Seifarth, W. ; Frank, O. ; Kramer, S. ; Brack-Werner, R. ; Leib-Mösch, C.
HIV-1 infection increases the expression of several HERV families.Kramer-Hämmerle, S. ; Ceccherini-Silberstein, F. ; Bickel, C. ; Wolff, H. ; Vincendeau, M. ; Werner, T. ; Erfle, V. ; Brack-Werner, R.
Identification of a novel Rev-interacting cellular protein.